Early detection of psychoemotional disorders in the acute period of ischemic stroke
Relevance of the topic: Stroke is the second leading cause of death and disability worldwide. In the last decade, much research has been conducted on physical rehabilitation after ischemic stroke, but there are few scientific studies on psychorchabilitation after stroke. However, depression after stroke is second only to depression resulting from Alzheimer's disease in etiology. Psychoanalytic tests alone arc not enough to detect psychoemotional disorders after ischemic stroke. In the early detection and treatment of the disease, the use of neurobiomarkers, genetic and biochemical testing methods are new and accurate diagnostic methods that help to indicate the level of psychoemotional disorders.
Today, it is assumed that biomarkers such as Oxidative stress biomarkers, Neuropeptide Y, PACAP are involved in the development of psychoemotional disorders after ischemic stroke and require their in-depth study. Studying the role of these biomarkers in the development of psychoemotional disorders after ischemic stroke will open new avenues in the etiopathogenesis and treatment of the disease.